19d)

Surveillance
Medical Treatment Surveillance
 Patients with CLTI have variable outcomes with regard to limb loss and overall mortality.
 After revascularization procedures, Patients remain on dual antiplatelet therapy (DAPT)
for 1-6 months.
 Through DAPT has been show to have increased bleeding risk, it may result in increased
survival and reduced risk of amputation. (Conte et al. 2019d)
 There is not a clear benefit to